Arbutus Biopharma
-
Warminster-Founded Arbutus Biopharma to Receive $190M in Moderna Settlement
Four years after suing Moderna over its Covid-19 vaccine, Arbutus Biopharma, which was formerly headquartered in Warminster, has secured a $190 million share of a…
-
Doylestown’s Pennsylvania Biotech Center Recruits Hepatitis C Cure Inventor
Michael J. Sofia, the inventor of the Hepatitis C cure, has joined the Pennsylvania Biotechnology Center in Doylestown, working towards a cure for Hepatitis B,…
-
Warminster Biopharma Firm Ends $285M Licensing Deal with Chinese Company
Warminster-based Arbutus Biopharma has ended a 4-year licensing deal worth up to $285 million with Qilu Pharmaceuticals, a Chinese drugmaker, writes John George for the…
-
Warminster-Based Arbutus Biopharma Lays Off Over Half of Workforce, Exits Its Headquarters
Warminster-based Arbutus Biopharma laid off over half of its workforce and is exiting its headquarters to conserve cash while continuing its pursuit of a hepatitis…
-
Large Shareholder Urges Warminster-based Arbutus to Seek Partners Instead of Selling More Stock
Whitefort Capital Management is urging Warminster-based Arbutus Biopharma to look at all options for its lead product portfolio instead of just diluting investor holdings by…
-
Warminster’s Arbutus Biopharma Achieves Breakthrough in Hepatitis B Treatment
Warminster biotech company Arbutus Biopharma shared promising results from its latest study on a new treatment for hepatitis B, writes John George for the Philadelphia…
-
Mike Sofia, Scientist Behind Hepatitis C Drug, Retires from Warminster-Based Arbutus Biopharma
Mike Sofia, a renowned scientist, is set to retire as Chief Scientific Officer at Warminster-based Arbutus Biopharma by the end of the year, writes John…
-
Arbutus Biopharma CEO William Collier Announces Retirement As Company Cuts 24 Percent
William Collier, president and CEO of Warminster-based Arbutus Biopharma, will retire from his positions effective December 31, writes John George for the Philadelphia Business Journal.…
-
Warminster Biopharmaceutical Company Takes Pharma Giants To Task in Lawsuit
A biopharmaceutical company in the Bucks County area is taking legal action against two major groups over their widely-lauded vaccines. John George wrote about the…
-
Arbutus Biopharma Corp., Warminster, Files Patent Infringement Lawsuit over COVID-19 Vaccine
Arbutus Biopharma Corp., Warminster, has filed a patent infringement lawsuit against Moderna Inc. The claim seeks unspecified damages related to Moderna’s widely distributed COVID-19 vaccine.…
-
Warminster’s Arbutus Biopharma Strikes Licensing-Partnering Deal with Chinese Pharma Firm
Arbutus Biopharma, Warminster, has entered a $300 million licensing and partnership deal with a Chinese biopharmaceutical firm. enters into $300M deal for experimental hepatitis B…
Founding Partners
Advertisement
Affiliate Partners
